Healionics Awarded $1.25M NIH Grant to Support Commercialization of STARgraft Vascular Graft
SEATTLE, WASHINGTON, USA, May 9, 2024 /EINPresswire.com/ — Healionics Corporation, a developer of biomaterial-based medical devices, today announced it has been awarded a $1.25 million Small Business Innovation Research grant by the National Heart, Lung, and Blood Institute to support the commercialization of its STARgraft vascular graft. The grant was provided under the National Institutes of Health Commercialization Readiness Pilot Program, which provides additional technical assistance and late-stage R&D support not typically covered within small business awards to help products get to market.
